IPO Details

About Company

Anthem Biosciences Limited, incorporated in 2006, is a leading innovation-driven Contract Research, Development, and Manufacturing Organization (CRDMO) based in India. The company offers fully integrated services across the drug lifecycle—including discovery, development, and commercial manufacturing—for both small molecules and biologics. It specializes in fermentation-based APIs, probiotics, enzymes, peptides, biosimilars, and advanced specialty ingredients. With a client base spanning over 44 countries—including the U.S., Europe, and Japan—Anthem serves biotech startups as well as large global pharmaceutical firms. As of September 30, 2024, it managed 196 active R&D and manufacturing projects, supported by a scientific team of 600+ professionals and multiple global patents and applications. The company operates state-of-the-art GMP-compliant facilities with the largest fermentation capacity among Indian CRDMOs and has shown strong revenue growth, driven by its technology-led, end-to-end service model and long-term customer partnerships.